Thats a very optimistic view, without evidence to support it.
- Forums
- ASX - By Stock
- CSL
- CSL - $300 and beyond
CSL - $300 and beyond, page-107
-
- There are more pages in this discussion • 22 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add CSL (ASX) to my watchlist
|
|||||
Last
$297.95 |
Change
-10.980(3.55%) |
Mkt cap ! $144.7B |
Open | High | Low | Value | Volume |
$300.03 | $301.28 | $297.77 | $97.81M | 326.1K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 39 | $297.94 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$297.97 | 84 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
6 | 49 | 298.670 |
8 | 62 | 298.660 |
3 | 19 | 298.650 |
3 | 38 | 298.620 |
2 | 31 | 298.610 |
Price($) | Vol. | No. |
---|---|---|
298.690 | 3 | 1 |
298.700 | 49 | 3 |
298.710 | 156 | 2 |
298.730 | 96 | 3 |
298.740 | 13 | 1 |
Last trade - 11.06am 13/08/2024 (20 minute delay) ? |
Featured News
CSL (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Steven Gourlay, Managing Director and CEO
Steven Gourlay
Managing Director and CEO
SPONSORED BY The Market Online